SUMMARY
INTRODUCTION
Recurrent pregnancy loss (RPL) is defined as three or more consecutive pregnancy losses prior to 20 weeks of gestation or less than 500 gram of fetus weight and occurring in % 0.5-1 of all pregnancies (1) . The abortus rate of the next pregnancy in a woman who has a spontaneous abortus is approximately % 20; after three miscarriages, this rate increased up to % 50 (2) . The causes of abortus is various and mostly unknown. A lot of reasons exhibit to explain the etiology of RPL. These are genetic, anatomic, endocrinological factors, placental abnormalities, infections, consumption of cigarette and alcohol, different environmental factors (ionizing radiation, consumption of chemical agent), and stress (3) .
Recently, thrombophilias become important in the etiology of RPL. Although investigations were made in unknown or unexplained cases of RPL, there were no reasons in most cases. In these cases, there were positive alive pregnancy rates to use low molecular weight heparin (LMWH) or aspirin (4) . Thus, the cause of thrombosis does not depend on one factor or the etiologic tests do not explain all reasons (5) . and decreasing the values of free Protein S (6) .
The natural anticoagulants such as antithrombin III (AT III) inactivate the activated factor X, IX, XII and especially thrombin. Although there was no important change in the levels of AT III in the pregnancy, there was a decrease in the levels in the delivery and postpartum one week (7) .
Procoagulation proteins such as Factor V and Factor VIII were inactivated by fragmenting with the natural anticoagulant Protein C. Protein S is a cofactor of Protein S. Although Protein C is constant or slight increase in pregnancy, Protein S decreases in an important meter (8) . During pregnancy, there was a new balance to occur thrombus because of the dominance of procoagulants to anticoagulants. The exclusion criteria were accepted as uterine anomalies leading to RPL, chronic systemic disease, and existence of antiphospholipid and anticardiolipin.
There was no difference between the study and control group for the age.
Patients included this study were informed and informed consent was obtained from all patients. Demographical features of patients, the number of abortus, the weeks of RPL, and the history of thrombosis and family were recorded. Venous blood samplings were collected by tubes with Nacitrate-EDTA from women of the patient In this prospective designed study, normally or nonnormally distributed groups were compared with Student-T and Mann-Whitney U tests. Additionally the values were written as means ± standard deviations.
All analyses were performed using SPSS 15.0.
RESULTS
The mean of the patients was 27.89 ± 5.66 in control group and 28.71 ± 5.64 in case group and there was no statistically difference between two groups (p= 0.50).
There were statistically significant differences between the groups for pregnancy, parity, abortus and alive baby (Table I ). and ovarian reserve defects. However, in most of cases, there were no etiologic factors (9) (10) .
Thrombophilias might be hereditary or acquired. AT III was firstly noticed then Protein C and Protein S were announced as hereditary thrombophilia reasons in order (11) . These three reasons may be responsible for % 5-15 (12) . In 1993, Dahlback et al. showed that plasma samples of patients with hereditary thrombophilia resisted against the anticoagulant effect of APC (13) . Hereditary thrombophilias such as APCR, Protein C and S deficiencies are mostly responsible for RPL (14) . Their effects on coagulation pathway were summarized in Table II . In the year of 1994, it was understood that APCR may depend on a point mutation in the gene of Factor V and this mutant gene was named as FVL. Although FVL is the most common reason for APCR, it is not unique cause. The patients with APCR are % 90 positive with FVL mutation (15) . Moreover, APCR is the most common reason for hereditary thrombophilias and covers % 20-50 of cases (16) (17) (18) . In another study about RPL, 34 of 184 patients had isolated APCR (19) . In our study, this rate is approximately % 14 and this rate is compatible with literature.
The prevalence of AT III deficiency in the community varied between 1/2000-1/5000. Hereditary AT III deficiency is autosomal dominant and most of cases are heterozygote (20, 21) . In our study, there was no patient with AT III deficiency. Protein C was synthesized from liver and was changed to serine protease anticoagulant activity by thrombin (22) . Its incidence is 1-5/1000. Protein C deficiency is autosomal dominant (23) . When the relation between fetal loss and hereditary thrombophilic disorder was examined, the women with combined deficiency and AT III deficiency had increased risk for obstetrical problems such as stillbirth (24) . In our study, 35 patients with > 2 RPL and healthy 53 control women were included. There was no statistically significant difference for ages of two groups.
APCR was measured in plasma with APTT based methods using with or without activated protein C (25) .
These methods are easy and cheap. It is sensitive both APCR Syndrome and FVL mutation. FVL mutation covers most of APCR cases in fact not at all. In another possibility, APTT based methods were applied in test plasma with FV absent plasma after dilution. In our study, APTT was increased in RPL group; this might be the result of increased APCR ratio in this group.
APCR is related with miscarriages, intrauterine growth retardation and fetal loss (25, 26) . There was a positive relation between RPL and Protein C, Protein S or AT III deficiencies (27) . Prophylactic LMWH usage in RPL cases with thrombophilia is related with increased pregnancy outcomes (28, 29) . However, aspirin usage in RPL does not affect pregnancy outcomes according to all meta-analysis and case-control studies (30) . Preston et al. exhibited that thrombophilia positive patient from 843 RPL patients had increased risk comparing with control (8) .
In our study, there were significant thrombophilia positive patients in RPL than control and the knowledge of thrombophilia is important to plan and follow next pregnancy. There are lots of studies for thrombophilia and RPL and their results are controversial. But our study indicated that thrombophilia in patients is pivotal for the prognosis of pregnancy and it might be considered for following of pregnancy.
